Biflavonoids from Selaginella doederleinii as Potential Antitumor Agents for Intervention of Non-Small Cell Lung Cancer

Molecules. 2021 Sep 5;26(17):5401. doi: 10.3390/molecules26175401.

Abstract

Four new biflavonoids (1-4) were isolated from Selaginella doederleinii together with a known biflavonoid derivative (5). Their structures contained a rare linker of individual flavones to each other by direct C-3-O-C-4''' bonds, and were elucidated by extensive spectroscopic data, including HRESIMS, NMR and ECD data. All isolates significantly inhibited the proliferation of NSCLC cells (IC50 = 2.3-8.4 μM) with low toxicity to non-cancer MRC-5 cells, superior to the clinically used drug DDP. Furthermore, the most active compound 3 suppressed XIAP and survivin expression, promoted upregulation of caspase-3/cleaved-caspase-3, as well as induced cell apoptosis and cycle arrest in A549 cells. Together, our findings suggest that 3 may be worth studying further for intervention of NSCLC.

Keywords: Selaginella doederleinii; antiproliferative activity; apoptosis; biflavonoid; cell cycle.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Biflavonoids / chemistry*
  • Biflavonoids / pharmacology
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Cell Cycle / drug effects
  • Humans
  • Lung Neoplasms / metabolism
  • Selaginellaceae / chemistry*

Substances

  • Antineoplastic Agents
  • Biflavonoids